Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

PURPOSE: To develop a system prognostic of outcome in those undergoing allogeneic hematopoietic cell transplantation (allo HCT) for myelodysplastic syndrome (MDS). PATIENTS AND METHODS: We examined 2,133 patients with MDS undergoing HLA-matched (n = 1,728) or -mismatched (n = 405) allo HCT from 2000...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Shaffer, Brian C., Ahn, Kwang Woo, Hu, Zhen-Huan, Nishihori, Taiga, Malone, Adriana K., Valcárcel, David, Grunwald, Michael R., Bacher, Ulrike, Hamilton, Betty, Kharfan-Dabaja, Mohamed A., Saad, Ayman, Cutler, Corey, Warlick, Erica, Reshef, Ran, Wirk, Baldeep Mona, Sabloff, Mitchell, Fasan, Omotayo, Gerds, Aaron, Marks, David, Olsson, Richard, Wood, William Allen, Costa, Luciano J., Miller, Alan M., Cortes, Jorge, Daly, Andrew, Kindwall-Keller, Tamila L., Kamble, Rammurti, Rizzieri, David A., Cahn, Jean-Yves, Gale, Robert Peter, William, Basem, Litzow, Mark, Wiernik, Peter H., Liesveld, Jane, Savani, Bipin N., Vij, Ravi, Ustun, Celalettin, Copelan, Edward, Popat, Uday, Kalaycio, Matt, Maziarz, Richard, Alyea, Edwin, Sobecks, Ron, Pavletic, Steven, Tallman, Martin, Saber, Wael
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2016
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966345/
https://ncbi.nlm.nih.gov/pubmed/27044940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.0515
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares